Consensus Evaxion A/S

Equities

EVAX

US29970R3030

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 12/03/2026 +04			5-day change	1st Jan Change
3.870 ^USD	+8.10%		+24.04%	-18.87%

03-10	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT
03-09	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT

Evolution of the Average Target: Evaxion A/S

Evolution of the Target Price: Evaxion A/S

Changes in Analyst Recommendations: Evaxion A/S

87ac.o0I5LTPytSDjK1AzY7avnv1IA09uhM_IZpJZTWFuJGc.5nEPVGfB0WLVWBNmEvHO-60_aSY76bmyNPYTLDQIQD7hKlxBd7bqaqR9FQ~00638213074869a97047737a8592db26

Analysts' recommendations: Evaxion A/S

25/09/25	HC Wainwright Adjusts Evaxion Biotech Price Target to $16 From $14, Maintains Buy Rating	MT
03/03/25	Certain Ordinary Shares of Evaxion A/S are subject to a Lock-Up Agreement Ending on 3-MAR-2025.	CI
02/04/24	Ladenburg Thalmann Upgrades Evaxion Biotech to Buy From Neutral, Price Target is $8	MT
12/02/24	HC Wainwright Initiates Evaxion Biotech With Buy Rating, Price Target is $14	MT
21/12/23	Ladenburg Thalmann Downgrades Evaxion Biotech to Neutral From Buy	MT
31/03/23	Lake Street Cuts Price Target on Evaxion Biotech to $7 From $18, Maintains Buy Rating	MT
17/11/22	Oppenheimer Adjusts Evaxion Biotech Price Target to $11 From $16, Maintains Outperform Rating	MT
30/07/21	EVAXION BIOTECH A/S : Lake Street Starts Evaxion Biotech at Buy With $21 Price Target	MT
02/03/21	EVAXION BIOTECH A/S : Oppenheimer Initiates Coverage on Evaxion Biotech With Outperform Rating, $18 Price Target	MT
02/03/21	EVAXION BIOTECH A/S : Ladenburg Starts Evaxion Biotech at Buy with $23 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	EVAXION A/S					+214.25%
	LONZA GROUP AG					+36.2%
	BEONE MEDICINES AG					+34.15%
	CELLTRION, INC.					+23.15%
	IQVIA HOLDINGS INC.					+38.18%
	REVOLUTION MEDICINES, INC.					+30.84%
	ASCENDIS PHARMA A/S					+18.76%
	MEDPACE HOLDINGS, INC.					+4.91%
	EUROFINS SCIENTIFIC SE					+12.64%
	Average					+45.90%
	Weighted average by Cap.					+28.69%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

4

Last Close Price

3.580USD

Average target price

11.25USD

Spread / Average Target

+214.25%

High Price Target

16.00USD

Spread / Highest target

+346.93%

Low Price Target

9.000USD

Spread / Lowest Target

+151.40%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Ladenburg Thalmann
Lake Street
Oppenheimer

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

4

Last Close Price

3.580USD

Average target price

11.25USD

Spread / Average Target

+214.25%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Equities
EVAX Stock
Consensus Evaxion A/S

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW